MHRA approves Astellas’ Vyloy combination for gastric cancer Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms
eXmoor pharma’s manufacturing facility receives licence from MHRA The company’s Cell & Gene Therapy Centre can now offer a full range of GMP services